Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (531-540 of 799) with videos related to

Pageof 80
Sort By:
BMC Cancer|February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patientsPeter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics|June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO surveyEvelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Breast (Edinburgh, Scotland)|January 29, 2019
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A studyMiriam Deniz, Amelie DeGregorio, Nikolaus DeGregorio, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and BiomarkersFlorin-Andrei Taran, Andreas Schneeweiss, Michael P Lux, et al.
Biochemical Pharmacology|December 7, 2011
Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001Christian R Loehberg, Pamela L Strissel, Ralf Dittrich, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and PreventionAndreas Schneeweiss, Michael P Lux, Wolfgang Janni, et al.
JAMA|October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenWerner Schroth, Matthew P Goetz, Ute Hamann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Fertility and Sterility|August 3, 2019
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancerKathryn J Ruddy, Daniel J Schaid, Ann H Partridge, et al.
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Pageof 80

Showing results (531-540 of 799) with videos related to

Sort By:
Pageof 80
BMC Cancer|February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patientsPeter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics|June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO surveyEvelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Breast (Edinburgh, Scotland)|January 29, 2019
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A studyMiriam Deniz, Amelie DeGregorio, Nikolaus DeGregorio, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and BiomarkersFlorin-Andrei Taran, Andreas Schneeweiss, Michael P Lux, et al.
Biochemical Pharmacology|December 7, 2011
Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001Christian R Loehberg, Pamela L Strissel, Ralf Dittrich, et al.
Geburtshilfe Und Frauenheilkunde|March 27, 2018
Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and PreventionAndreas Schneeweiss, Michael P Lux, Wolfgang Janni, et al.
JAMA|October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenWerner Schroth, Matthew P Goetz, Ute Hamann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Fertility and Sterility|August 3, 2019
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancerKathryn J Ruddy, Daniel J Schaid, Ann H Partridge, et al.
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Pageof 80